Journal ArticleDOI
Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology, Pathology, Biology, Endocrine Surgery and Head and Neck Surgery.
Slimane Zerdoud,Anne-Laure Giraudet,Sophie Leboulleux,Laurence Leenhardt,Stéphane Bardet,Jérôme Clerc,Marie-Elisabeth Toubert,Abir Al Ghuzlan,Pierre-Jean Lamy,Claire Bournaud,Isabelle Keller,Frederic Sebag,Renaud Garrel,Eric Mirallié,Lionel Groussin,Elif Hindié,David Taïeb +16 more
Reads0
Chats0
TLDR
Slimane Zerdoud a, Anne-Laure Giraudet b, Sophie Leboulleux c, Laurence Leenhardt d, Stéphane Bardet e, Jérôme Clerc f, Marie-Elisabeth Toubert g, Abir Al Ghuzlan.Abstract:
Slimane Zerdoud a, Anne-Laure Giraudet b, Sophie Leboulleux c, Laurence Leenhardt d, Stéphane Bardet e, Jérôme Clerc f, Marie-Elisabeth Toubert g, Abir Al Ghuzlan h, Pierre-Jean Lamy i,j, Claire Bournaud k, Isabelle Keller l, Frédéric Sebag m, Renaud Garrel n, Eric Mirallié o, Lionel Groussin p, Elif Hindié q,∗, David Taïeb r,∗ a Service de médecine nucléaire, institut universitaire du cancer Toulouse oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France b Médecine nucleaire, centre LUMEN, curiethérapie, thyroïde, tumeurs endocrines, centre de lutte contre le cancer Léon-Berard, 28, rue Laennec, 69008 Lyon, France c Service de médecine nucléaire et cancérologie endocrinienne Gustave-Roussy, université Paris Saclay, 114, rue Edouard-Vaillant, 94805 Villejuif, France d Unité thyroïde tumeurs endocrines, institut E3M, hôpital La Pitié-Salpêtrière, 83, boulevard de l’Hôpital, 75013 Paris, France e Service de médecine nucléaire et UCP thyroïde, centre François-Baclesse, 3, avenue Général-Harris, 14076 Caen cedex 05, France f Service de médecine nucléaire, groupe hospitalier Paris Centre, AP–HP, 27, rue du Faubourg-Saint-Jacques, 75679 Paris cedex 14, France g Service de médecine nucléaire, hôpital Saint-Louis, AP–HP, 1, avenue Claude-Vellefaux, 75475 Paris cedex 10, France h Département de biologie et de pathologie médicales Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif, France i Laboratoire d’oncologie moléculaire, institut médical d’analyse génomique, Labosud, 141, avenue Paul-Bringuier, 34080 Montpellier, France j Unité de recherche clinique, clinique Beau-Soleil, 119, avenue de Lodeve, 34070 Montpellier, France k Service de médecine nucléaire, hospices civils de Lyon, groupement hospitalier Est, 28, avenue Doyen-Lépine, 69677 Bron cedex, France l Service de médecine nucléaire, hôpitaux universitaires Est Parisien, hôpital Saint-Antoine, AP–HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France m Service de chirurgie endocrinienne, université Aix-Marseille, CHU de la Timone, 264, rue Saint-Pierre, 13005 Marseille, France n Département ORL et chirurgie cervico faciale, pole neuroscience tête et cou, hôpital Gui-de-Chauliac, CHU de Montpellier, 80, rue Fliche, 34295 Montpellier, France o Service de chirurgie endocrinienne et digestive, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes, France p Service d’endocrinologie et maladies métaboliques, hôpital Cochin, AP–HP, 123, boulevard du Port-Royal, 75014 Paris, France q Service de médecine nucléaire, hôpital Haut-Lévêque, université de Bordeaux, CHU de Bordeaux, avenue Magellan, 33604 Pessac, France r Service central de biophysique et de médecine nucléaire, université Aix-Marseille, CHU de la Timone, 264, rue Saint-Pierre, 13005 Marseille cedex 05, Franceread more
Citations
More filters
Journal ArticleDOI
The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells.
Mathilde Bauriaud-Mallet,Lavinia Vija-Racaru,Severine Brillouet,Arnaud Mallinger,Philippe de Medina,Arnaud Rives,Bruno Payré,Marc Poirot,Frédéric Courbon,Sandrine Silvente-Poirot +9 more
TL;DR: The re-differentiation of breast and thyroid cancer cells by DDA, is associated with the recovery of functional NIS expression and involves an LXR-dependent mechanism, which open new avenues of research for the diagnosis of thyroid cancers as well as the development of new therapeutic approaches for radioiodine refractory thyroid cancers.
Journal ArticleDOI
Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system
N Chereau,Taofik Oyekunle,Alan Zambeli-Ljepovic,Hadiza S. Kazaure,Sanziana A. Roman,F Menegaux,Julie Ann Sosa +6 more
TL;DR: The hypothesis of this study was that the eighth edition of the AJCC system can be used in this novel way to predict survival in papillary thyroid cancer.
Journal ArticleDOI
A Matter of Controversy: Is Radioiodine Therapy Favorable in Differentiated Thyroid Carcinoma?
TL;DR: Why the use of radioiodine therapy in more than only high-risk patients should be advocated, including tumor stage, extent of surgery, tumor biology, clinical and imaging data, life expectancy, and patient preferences.
Journal ArticleDOI
NIFT-P: Are they indolent tumors? Results of a multi-institutional study
Nathalie Chereau,Tristan Greilsamer,Eric Mirallié,Samira M. Sadowski,Marc Pusztaszeri,Frédéric Triponez,Gregory Baud,François Pattou,Niki Christou,Muriel Mathonnet,Laurent Brunaud,Nicolas Santucci,Pierre Goudet,Carole Guerin,Frederic Sebag,Gianluca Donatini,Jean-Louis Kraimps,Frédérique Tissier,Charlotte Lussey-Lepoutre,Laurence Leenhardt,Fabrice Menegaux +20 more
TL;DR: It is found that noninvasive follicular thyroid neoplasm with papillary‐like nuclear features presents with indolent behavior and should be carefully evaluated because it could be a factor for lymph node metastasis and/or of recurrence.
Journal ArticleDOI
Risk of recurrence in patients with papillary thyroid carcinoma and minimal extrathyroidal extension not treated with radioiodine.
TL;DR: The results suggest that patients with mETE and without other adverse features, who have low nonstimulated Tg and negative neck US after thyroidectomy, do not require ablation with RAI.
References
More filters
Journal ArticleDOI
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R. Haugen,Erik K. Alexander,Keith C. Bible,Gerard M. Doherty,Susan J. Mandel,Yuri E. Nikiforov,Furio Pacini,Gregory W. Randolph,Anna M. Sawka,Martin Schlumberger,Kathryn G. Schuff,Steven I. Sherman,Julie Ann Sosa,David L. Steward,R. Michael Tuttle,Leonard Wartofsky +15 more
TL;DR: Evidence-based recommendations are developed to inform clinical decision-making in the management of thyroid nodules and differentiated thyroid cancer and represent, in the authors' opinion, contemporary optimal care for patients with these disorders.
Journal ArticleDOI
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
David S. Cooper,Gerard M. Doherty,Bryan R. Haugen,Richard T. Kloos,Stephanie L. Lee,Susan J. Mandel,Ernest L. Mazzaferri,Bryan McIver,Furio Pacini,Martin Schlumberger,Steven I. Sherman,David L. Steward,R. Michael Tuttle +12 more
TL;DR: Evidence-based recommendations in response to the appointment as an independent task force by the American Thyroid Association to assist in the clinical management of patients with thyroid nodules and differentiated thyroid cancer represent, in the authors' opinion, contemporary optimal care for patients with these disorders.
Journal ArticleDOI
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
Furio Pacini,Martin Schlumberger,Henning Dralle,Rossella Elisei,Johannes W. A. Smit,Wilmar M. Wiersinga +5 more
TL;DR: European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Furio Pacini, Martin Schlumberger, Henning Dralle, Rossella Elisei, Johannes W A Smit, Wilmar Wiersinga and the European Thyroid Cancer Taskforce Section of Endocrinology and Metabolism are presented.
Journal ArticleDOI
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger,Makoto Tahara,Lori J. Wirth,Bruce G. Robinson,Marcia S. Brose,Rossella Elisei,Mouhammed Amir Habra,Kate Newbold,Manisha H. Shah,Ana O. Hoff,Andrew G. Gianoukakis,Naomi Kiyota,Matthew H. Taylor,Sung Bae Kim,Monika K. Krzyzanowska,Corina E. Dutcus,B.D.L. Heras,J. Zhu,Steven I. Sherman +18 more
TL;DR: Lenvatinib, as compared with placebo, was associated with significant improvements in progression-free survival and the response rate among patients with iodine-131-refractory thyroid cancer.
Journal ArticleDOI
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
TL;DR: The approach to treatment of papillary and follicular cancer is usually very similar, and DTC is more likely to be completely resected and ablated with iodine-131 (I), an approach that has become more popular in the past several decades when discovered at an early stage.
Related Papers (5)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
Ujjal Mallick,Clive Harmer,Beng K. Yap,Jonathan Wadsley,Susan E. M. Clarke,Laura Moss,Alice Nicol,Penelope M. Clark,Kate Farnell,Ralph V McCready,James Smellie,J. A. Franklyn,Rhys John,Christopher M. Nutting,Kate Newbold,Catherine Lemon,Georgina Gerrard,Abdel Abdel-Hamid,John Hardman,Elena Macias,Tom Roques,Stephen Whitaker,Rengarajan Vijayan,Pablo Alvarez,Sandy Beare,Sharon Forsyth,Latha Kadalayil,Allan Hackshaw +27 more
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
Martin Schlumberger,B. Catargi,Isabelle Borget,Désirée Deandreis,Slimane Zerdoud,B. Bridji,Stéphane Bardet,Laurence Leenhardt,Delphine Bastie,Claire Schvartz,Pierre Vera,Olivier Morel,Danielle Benisvy,Claire Bournaud,Fran ccoise Bonichon,C. Dejax,Marie-Elisabeth Toubert,Sophie Leboulleux,Marcel Ricard,Ellen Benhamou +19 more